The invention provides agents and methods for treatment of diseases associated with Lewy body diseases (LBDs) in the brain of a patient. Preferred agents include inhibitors of PLK2 and GRK6 kinases.

 
Web www.patentalert.com

< Monitoring APP cleavage in transgenic rodents comprising an APP Swedish mutation

> Compounds to treat Alzheimer's disease

> Fluid analyser systems
~ 00529